CAEME

What CAEME does

CAEME (Cámara Argentina de Especialidades Medicinales) is a non-profit industry chamber founded in 1923 in Buenos Aires, representing pharmaceutical and biotechnology companies that develop, manufacture, and commercialize innovative medicines in Argentina. The organization is the unified industry voice on clinical research, pharmacovigilance, digital transformation in healthcare, and evidence-based medicine, and it does not directly commercialize products — its members distribute medicines through Argentina's standard pharmacy, hospital, and healthcare-provider channels. CAEME's revenue model is a subscription/recurring membership-dues structure (exact fee schedules are not publicly disclosed and are presumably tiered by company size and participation level), and the chamber operates with a small internal staff (11–50 employees) supported by member-company engagement.

Programmatically, CAEME runs an annual Innovation Day conference, the Ideatón Salud open innovation challenge, the Informe Weber annual industry report, and a directory of Argentine patient associations that connects member companies with advocacy groups across conditions such as rheumatoid arthritis, cancer, multiple sclerosis, hepatitis C, muscular dystrophy, short stature, osteogenesis imperfecta, and atopic dermatitis. It publishes self-regulatory instruments — a Code of Ethics, a Code of Good Promotional Practices, and a Policy on Interactions with Public Officials — and collaborates with Argentina's Secretaría de Innovación, Ciencia y Tecnología de la Nación on the ESID survey of business-sector R&D and with CAOIC on the annual clinical-investment survey.

Scale-wise, CAEME's member companies collectively invest approximately USD 700 million annually in clinical R&D in Argentina, operate 10 production plants, employ more than 9,000 direct qualified workers, and are running more than 1,000 clinical trials with over 50,000 participants (per the ESID 2023 and CAEME-CAOIC 2023 surveys). Geographic scope is domestic — Argentina is the sole served market, with no global footprint claim. There is no AI/ML technology stack, no app, no API, and no proprietary digital products disclosed; CAEME's technology layer is best characterized as an information and coordination platform rather than a software platform.

Name

CAEME

Legal name

Cámara Argentina de Especialidades Medicinales

Website

https://caeme.org.ar

Company type

Private

Founded year

1923

Operating status

Operating

Headcount range

11–50 employees

Short description

CAEME (Cámara Argentina de Especialidades Medicinales) is a Buenos Aires-based non-profit industry chamber founded in 1923 that represents innovative pharmaceutical companies in Argentina. It advocates for the sector, promotes clinical research and pharmacovigilance, and runs programs such as Innovation Day, Ideatón Salud, and the Informe Weber.

Ownership category

akta.pro rank

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership dues: CAEME operates as a chamber of commerce for pharmaceutical companies. Revenue comes from membership dues paid by pharmaceutical company members, which fund industry advocacy, research initiatives, and healthcare programs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

CAEME is a non-profit industry chamber representing pharmaceutical and biotechnology companies in Argentina. It provides industry advocacy, clinical research support, pharmacovigilance resources, policy engagement, and member programs such as Innovation Day, Ideatón Salud, and the Informe Weber report to advance pharmaceutical innovation, evidence-based medicine, and patient access to innovative treatments.

Product overview

CAEME (Cámara Argentina de Especialidades Medicinales) is a pharmaceutical industry association representing innovative medicinal product companies in Argentina. Rather than offering commercial products, CAEME provides industry programs and initiatives including clinical research support, pharmacovigilance services, digital transformation resources, patient association listings, and events such as Innovation Day, the Ideatón Salud program, and the Weber Report. CAEME focuses on promoting innovation, research excellence, and quality standards in the pharmaceutical sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Ideatón Salud

Quantifiable outcome

• 5 million deaths avoided annually worldwide through vaccination
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• Secretaría de Innovación, Ciencia y Tecnología de la NacióncoreStrategic or Co-development PartnerCAEME collaborates with the Argentine Ministry of Science and Technology on surveys regarding R&D in the pharmaceutical sector, contributing data for the 'Encuesta sobre I+D del Sector Empresario Argentino' (ESID) 2023.
• CAEME Member CompaniescoreOthersCAEME represents pharmaceutical companies that are members of the chamber, including leading international pharmaceutical companies operating in Argentina.
• Patient Associations (A.M.A.R, ACIAPO, ALCEM, and others)coreGTM or Marketing PartnerCAEME maintains a directory of patient associations including organizations for arthritis (A.M.A.R), cancer (ACIAPO), multiple sclerosis (ALCEM), and other conditions, facilitating collaboration between member companies and patient advocacy groups.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• EFPIA (European Federation of Pharmaceutical Industries and Associations): European-level federation representing the research-based pharmaceutical industry across the EU. Comparable as an industry-association advocacy body for innovative pharma, but at a supranational scale and with a much broader policy portfolio than a single-country chamber like CAEME.
• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global federation of pharma industry associations (CAEME-type chambers). Comparable because IFPMA's membership model and policy-advocacy focus mirror what CAEME does at the country level, but IFPMA operates globally with no commercial or clinical-research program equivalent to CAEME's Innovation Day or ESID partnership.
• PhRMA (Pharmaceutical Research and Manufacturers of America): The largest and best-resourced innovative-pharma industry association globally, representing US-based research pharma. Comparable in core mandate (advocacy for innovative-medicines companies on pricing, IP, and regulation) but operates at vastly larger scale and across a more diversified market than CAEME.

Regional players

• ABPI (Association of the British Pharmaceutical Industry): UK trade association for the research-based pharmaceutical industry. Structurally identical to CAEME — national chamber representing innovative pharma on regulation, ethics, and market access — but operating in the mature UK market with a much larger dues base.
• INTERFARMA (Associação da Indústria Farmacêutica de Pesquisa): Brazilian pharmaceutical industry association representing research-based pharma companies. Highly comparable to CAEME in mandate (representing innovative medicines in a major LatAm market), regional scope, and advocacy-heavy operating model, but Brazil-only.
• FIFARMA (Federación Latinoamericana de la Industria Farmacéutica): Latin American federation of national pharma industry chambers, of which CAEME is a natural constituent. Highly comparable as the regional umbrella CAEME engages with; FIFARMA coordinates policy positions across members including CAEME, INTERFARMA, and CANIFARMA.
• CANIFARMA (Cámara Nacional de la Industria Farmacéutica): Mexican national pharma industry chamber representing both national and multinational pharma manufacturers operating in Mexico. Directly comparable in role to CAEME — national pharma trade association covering R&D, regulation, and advocacy — but serving Mexico rather than Argentina.

Direct peers

• CILFA (Cámara Industrial de Laboratorios Farmacéuticos Argentinos): Argentina's other major pharma industry chamber, focused on national-laboratory pharmaceutical manufacturers. Direct peer because both serve as industry associations representing pharma companies within the same Argentine regulatory and political environment, and they compete for the same Argentine pharma executive audience.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/caemear
• Facebookfacebook.com/CAEMEar
• LinkedInlinkedin.com/company/caeme

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAEME